1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary
Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
4. Voice of Customer
5. Global Maternal Mental Health Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By
Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and
Postpartum General Anxiety, Pregnancy
and Postpartum OCD, Birth-Related
PTSD, Others)
5.2.2. By Therapy (Interpersonal
Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Maternal Mental Health
Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Disease Indication
6.2.2. By Therapy
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Maternal Mental Health
Market Outlook
6.3.1.1. Market Size
& Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share
& Forecast
6.3.1.2.1. By Disease Indication
6.3.1.2.2. By Therapy
6.3.2. Canada Maternal Mental Health
Market Outlook
6.3.2.1. Market Size
& Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share
& Forecast
6.3.2.2.1. By Disease Indication
6.3.2.2.2. By Therapy
6.3.3. Mexico Maternal Mental Health
Market Outlook
6.3.3.1. Market Size
& Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share
& Forecast
6.3.3.2.1. By Disease Indication
6.3.3.2.2. By Therapy
7. Europe Maternal Mental Health
Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Disease Indication
7.2.2. By Therapy
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Maternal Mental Health
Market Outlook
7.3.1.1. Market Size
& Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share
& Forecast
7.3.1.2.1. By Disease Indication
7.3.1.2.2. By Therapy
7.3.2. United Kingdom Maternal Mental Health
Market Outlook
7.3.2.1. Market Size
& Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share
& Forecast
7.3.2.2.1. By Disease Indication
7.3.2.2.2. By Therapy
7.3.3. Italy Maternal Mental Health
Market Outlook
7.3.3.1. Market Size
& Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share
& Forecasty
7.3.3.2.1. By Disease Indication
7.3.3.2.2. By Therapy
7.3.4. France Maternal Mental Health
Market Outlook
7.3.4.1. Market Size
& Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share
& Forecast
7.3.4.2.1. By Disease Indication
7.3.4.2.2. By Therapy
7.3.5. Spain Maternal Mental Health
Market Outlook
7.3.5.1. Market Size
& Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share
& Forecast
7.3.5.2.1. By Disease Indication
7.3.5.2.2. By Therapy
8. Asia-Pacific Maternal Mental Health
Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Disease Indication
8.2.2. By Therapy
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Maternal Mental Health
Market Outlook
8.3.1.1. Market Size
& Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share
& Forecast
8.3.1.2.1. By Disease Indication
8.3.1.2.2. By Therapy
8.3.2. India Maternal Mental Health
Market Outlook
8.3.2.1. Market Size
& Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share
& Forecast
8.3.2.2.1. By Disease Indication
8.3.2.2.2. By Therapy
8.3.3. Japan Maternal Mental Health
Market Outlook
8.3.3.1. Market Size
& Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share
& Forecast
8.3.3.2.1. By Disease Indication
8.3.3.2.2. By Therapy
8.3.4. South Korea Maternal Mental Health
Market Outlook
8.3.4.1. Market Size
& Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share
& Forecast
8.3.4.2.1. By Disease Indication
8.3.4.2.2. By Therapy
8.3.5. Australia Maternal Mental Health
Market Outlook
8.3.5.1. Market Size
& Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share
& Forecast
8.3.5.2.1. By Disease Indication
8.3.5.2.2. By Therapy
9. South America Maternal Mental Health
Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Disease Indication
9.2.2. By Therapy
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Maternal Mental Health
Market Outlook
9.3.1.1. Market Size
& Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share
& Forecast
9.3.1.2.1. By Disease Indication
9.3.1.2.2. By Therapy
9.3.2. Argentina Maternal Mental Health
Market Outlook
9.3.2.1. Market Size
& Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share
& Forecast
9.3.2.2.1. By Disease Indication
9.3.2.2.2. By Therapy
9.3.3. Colombia Maternal Mental Health
Market Outlook
9.3.3.1. Market Size
& Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share
& Forecast
9.3.3.2.1. By Disease Indication
9.3.3.2.2. By Therapy
10. Middle East and Africa Maternal Mental
Health Market Outlook
10.1. Market Size &
Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Disease Indication
10.2.2. By Therapy
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Maternal Mental Health
Market Outlook
10.3.1.1. Market Size
& Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share
& Forecast
10.3.1.2.1. By Disease Indication
10.3.1.2.2. By Therapy
10.3.2. Saudi Arabia Maternal Mental Health
Market Outlook
10.3.2.1. Market Size
& Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share
& Forecast
10.3.2.2.1. By Disease Indication
10.3.2.2.2. By Therapy
10.3.3. UAE Maternal Mental Health
Market Outlook
10.3.3.1. Market Size
& Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share
& Forecast
10.3.3.2.1. By Disease Indication
10.3.3.2.2. By Therapy
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition
12.2. Product Development
12.3. Recent Developments
13. Global Maternal Mental Health
Market: SWOT Analysis
14. Competitive Landscape
14.1. Therapy Mama
14.1.1. Business Overview
14.1.2. Application Offerings
14.1.3. Recent Developments
14.1.4. Key Personnel
14.1.5. SWOT Analysis
14.2. Canopie
14.3. Pfizer Inc
14.4. Viatris Inc.
14.5. GlaxoSmithKline Inc.
14.6. Alembic Pharmaceuticals Limited
14.7. Mallinckrodt Inc.
14.8. Sage Therapeutics, Inc.
14.9. Bausch Health Companies Inc.
14.10. Magellan Health, Inc.
15. Strategic
Recommendations
16. About Us & Disclaimer